POU6F2, POU class 6 homeobox 2, 11281

N. diseases: 29; N. variants: 16
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.100 Biomarker group HPO
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 Biomarker group HPO
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.100 Biomarker group HPO
CUI: C0497156
Disease: Lymphadenopathy
Lymphadenopathy
0.100 Biomarker phenotype HPO
CUI: C0544886
Disease: Somatic mutation
Somatic mutation
0.100 Biomarker phenotype HPO
CUI: C1262477
Disease: Weight decreased
Weight decreased
0.100 Biomarker phenotype HPO
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 AlteredExpression group BEFREE The murine Pou6f2 gene is temporally and spatially regulated during kidney embryogenesis and its human homolog is overexpressed in a subset of Wilms tumors. 17164647 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 GeneticVariation group BEFREE No alteration of the WT1 and POU6F2 genes was identified in constitutional and tumor DNA of both sisters, and no anomaly in WT1 expression was evidenced in the normal kidney of one of them. 16217254 2005
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 GeneticVariation group BEFREE Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14. 15459955 2004
CUI: C1333015
Disease: Childhood Kidney Wilms Tumor
Childhood Kidney Wilms Tumor
0.020 Biomarker disease BEFREE The finding of a highly regulated temporal and spatial Pou6f2 expression during renal organogenesis, of its coexpression with Wt1 and of POU6F2 overexpression in a subset of WTs are consistent with a role of POU6F2 in kidney development and provide further support to its involvement in WT. 17164647 2006
CUI: C1333015
Disease: Childhood Kidney Wilms Tumor
Childhood Kidney Wilms Tumor
0.020 GeneticVariation disease BEFREE Together with the finding of the expression of the POU6F2 mouse homolog in both fetal and adult kidney, our observations suggest that the gene is a tumor suppressor and is involved in hereditary predisposition to WT. 15459955 2004
CUI: C0033375
Disease: Prolactinoma
Prolactinoma
0.010 Biomarker disease BEFREE POU6F2 might play a crucial role in the development of prolactinomas and may be a promising target for developing new therapies against prolactinomas. 31692290 2019
CUI: C0017601
Disease: Glaucoma
Glaucoma
0.010 GeneticVariation disease BEFREE In addition, these POU6F2 RGCs die early in the DBA/2J model of glaucoma than most RGCs. 29370175 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 GeneticVariation group BEFREE Through these integrated genomic analyses, MECT1-MAML2 translocation and somatic TP53 and POU6F2 mutations appear to be the main drivers of MEC.Clin Cancer Res; 23(1); 283-8.©2016 AACR. 27340278 2017
CUI: C0206694
Disease: Mucoepidermoid Carcinoma
Mucoepidermoid Carcinoma
0.010 GeneticVariation disease BEFREE POU6F2 was the second most frequently mutated gene, found in three low-grade MECs with the same in-frame deletion. 27340278 2017
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.010 GeneticVariation group BEFREE Through these integrated genomic analyses, MECT1-MAML2 translocation and somatic TP53 and POU6F2 mutations appear to be the main drivers of MEC.Clin Cancer Res; 23(1); 283-8.©2016 AACR. 27340278 2017